Log in
ETR:AFX

Carl Zeiss Meditec AG (AFX.F) Competitors

€118.70
-3.10 (-2.55 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
€114.60
Now: €118.70
€119.30
50-Day Range
€92.85
MA: €106.27
€122.40
52-Week Range
€67.70
Now: €118.70
€123.90
Volume215,714 shs
Average Volume94,405 shs
Market Capitalization$10.62 billion
P/E Ratio88.91
Dividend Yield0.55%
BetaN/A

Competitors

Carl Zeiss Meditec AG (AFX.F) (ETR:AFX) Vs. BAYN, SHL, FME, MRK, SRT, and EVT

Should you be buying AFX stock or one of its competitors? Companies in the sector of "medical" are considered alternatives and competitors to Carl Zeiss Meditec AG (AFX.F), including Bayer (BAYN), Siemens Healthineers (SHL), Fresenius Medical Care AG & Co. KGaA (FME.F) (FME), MERCK Kommanditgesellschaft auf Aktien (MRK.F) (MRK), Sartorius (SRT), and Evotec (EVT).

Bayer (ETR:BAYN) and Carl Zeiss Meditec AG (AFX.F) (ETR:AFX) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, dividends and risk.

Profitability

This table compares Bayer and Carl Zeiss Meditec AG (AFX.F)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BayerN/AN/AN/A
Carl Zeiss Meditec AG (AFX.F)N/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Bayer and Carl Zeiss Meditec AG (AFX.F), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bayer0000N/A
Carl Zeiss Meditec AG (AFX.F)34201.89

Carl Zeiss Meditec AG (AFX.F) has a consensus price target of €102.25, indicating a potential downside of 13.86%. Given Carl Zeiss Meditec AG (AFX.F)'s higher probable upside, analysts clearly believe Carl Zeiss Meditec AG (AFX.F) is more favorable than Bayer.

Earnings & Valuation

This table compares Bayer and Carl Zeiss Meditec AG (AFX.F)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bayer$43.48 billion0.96$-5,615,535,584.00(€5.72)-7.42
Carl Zeiss Meditec AG (AFX.F)$1.40 billion7.59$119.40 million€1.3488.91

Carl Zeiss Meditec AG (AFX.F) has lower revenue, but higher earnings than Bayer. Bayer is trading at a lower price-to-earnings ratio than Carl Zeiss Meditec AG (AFX.F), indicating that it is currently the more affordable of the two stocks.

Dividends

Bayer pays an annual dividend of €2.80 per share and has a dividend yield of 6.6%. Carl Zeiss Meditec AG (AFX.F) pays an annual dividend of €0.65 per share and has a dividend yield of 0.5%. Bayer pays out -49.0% of its earnings in the form of a dividend. Carl Zeiss Meditec AG (AFX.F) pays out 48.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bayer is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Carl Zeiss Meditec AG (AFX.F) beats Bayer on 6 of the 9 factors compared between the two stocks.

Siemens Healthineers (ETR:SHL) and Carl Zeiss Meditec AG (AFX.F) (ETR:AFX) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, dividends and risk.

Profitability

This table compares Siemens Healthineers and Carl Zeiss Meditec AG (AFX.F)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Siemens HealthineersN/AN/AN/A
Carl Zeiss Meditec AG (AFX.F)N/AN/AN/A

Dividends

Siemens Healthineers pays an annual dividend of €0.80 per share and has a dividend yield of 2.1%. Carl Zeiss Meditec AG (AFX.F) pays an annual dividend of €0.65 per share and has a dividend yield of 0.5%. Siemens Healthineers pays out 54.1% of its earnings in the form of a dividend. Carl Zeiss Meditec AG (AFX.F) pays out 48.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Siemens Healthineers and Carl Zeiss Meditec AG (AFX.F), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Siemens Healthineers27702.31
Carl Zeiss Meditec AG (AFX.F)34201.89

Siemens Healthineers currently has a consensus price target of €42.37, indicating a potential upside of 11.11%. Carl Zeiss Meditec AG (AFX.F) has a consensus price target of €102.25, indicating a potential downside of 13.86%. Given Siemens Healthineers' stronger consensus rating and higher probable upside, research analysts clearly believe Siemens Healthineers is more favorable than Carl Zeiss Meditec AG (AFX.F).

Earnings & Valuation

This table compares Siemens Healthineers and Carl Zeiss Meditec AG (AFX.F)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Siemens Healthineers$14.73 billion2.59$1.48 billion€1.4825.80
Carl Zeiss Meditec AG (AFX.F)$1.40 billion7.59$119.40 million€1.3488.91

Siemens Healthineers has higher revenue and earnings than Carl Zeiss Meditec AG (AFX.F). Siemens Healthineers is trading at a lower price-to-earnings ratio than Carl Zeiss Meditec AG (AFX.F), indicating that it is currently the more affordable of the two stocks.

Summary

Siemens Healthineers beats Carl Zeiss Meditec AG (AFX.F) on 7 of the 10 factors compared between the two stocks.

Carl Zeiss Meditec AG (AFX.F) (ETR:AFX) and Fresenius Medical Care AG & Co. KGaA (FME.F) (ETR:FME) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

Profitability

This table compares Carl Zeiss Meditec AG (AFX.F) and Fresenius Medical Care AG & Co. KGaA (FME.F)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Carl Zeiss Meditec AG (AFX.F)N/AN/AN/A
Fresenius Medical Care AG & Co. KGaA (FME.F)N/AN/AN/A

Dividends

Carl Zeiss Meditec AG (AFX.F) pays an annual dividend of €0.65 per share and has a dividend yield of 0.5%. Fresenius Medical Care AG & Co. KGaA (FME.F) pays an annual dividend of €1.20 per share and has a dividend yield of 1.7%. Carl Zeiss Meditec AG (AFX.F) pays out 48.7% of its earnings in the form of a dividend. Fresenius Medical Care AG & Co. KGaA (FME.F) pays out 27.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Fresenius Medical Care AG & Co. KGaA (FME.F) is clearly the better dividend stock, given its higher yield and lower payout ratio.

Analyst Recommendations

This is a summary of recent ratings for Carl Zeiss Meditec AG (AFX.F) and Fresenius Medical Care AG & Co. KGaA (FME.F), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Carl Zeiss Meditec AG (AFX.F)34201.89
Fresenius Medical Care AG & Co. KGaA (FME.F)061002.63

Carl Zeiss Meditec AG (AFX.F) currently has a consensus price target of €102.25, indicating a potential downside of 13.86%. Fresenius Medical Care AG & Co. KGaA (FME.F) has a consensus price target of €83.29, indicating a potential upside of 21.34%. Given Fresenius Medical Care AG & Co. KGaA (FME.F)'s stronger consensus rating and higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA (FME.F) is more favorable than Carl Zeiss Meditec AG (AFX.F).

Earnings & Valuation

This table compares Carl Zeiss Meditec AG (AFX.F) and Fresenius Medical Care AG & Co. KGaA (FME.F)'s revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Carl Zeiss Meditec AG (AFX.F)$1.40 billion7.59$119.40 million€1.3488.91
Fresenius Medical Care AG & Co. KGaA (FME.F)$18.04 billion1.16$1.34 billion€4.3915.65

Fresenius Medical Care AG & Co. KGaA (FME.F) has higher revenue and earnings than Carl Zeiss Meditec AG (AFX.F). Fresenius Medical Care AG & Co. KGaA (FME.F) is trading at a lower price-to-earnings ratio than Carl Zeiss Meditec AG (AFX.F), indicating that it is currently the more affordable of the two stocks.

Summary

Fresenius Medical Care AG & Co. KGaA (FME.F) beats Carl Zeiss Meditec AG (AFX.F) on 8 of the 10 factors compared between the two stocks.

Carl Zeiss Meditec AG (AFX.F) (ETR:AFX) and MERCK Kommanditgesellschaft auf Aktien (MRK.F) (ETR:MRK) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Valuation and Earnings

This table compares Carl Zeiss Meditec AG (AFX.F) and MERCK Kommanditgesellschaft auf Aktien (MRK.F)'s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Carl Zeiss Meditec AG (AFX.F)$1.40 billion7.59$119.40 million€1.3488.91
MERCK Kommanditgesellschaft auf Aktien (MRK.F)$16.92 billion1.01$417.71 million€3.2340.80

MERCK Kommanditgesellschaft auf Aktien (MRK.F) has higher revenue and earnings than Carl Zeiss Meditec AG (AFX.F). MERCK Kommanditgesellschaft auf Aktien (MRK.F) is trading at a lower price-to-earnings ratio than Carl Zeiss Meditec AG (AFX.F), indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Carl Zeiss Meditec AG (AFX.F) and MERCK Kommanditgesellschaft auf Aktien (MRK.F)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Carl Zeiss Meditec AG (AFX.F)N/AN/AN/A
MERCK Kommanditgesellschaft auf Aktien (MRK.F)N/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Carl Zeiss Meditec AG (AFX.F) and MERCK Kommanditgesellschaft auf Aktien (MRK.F), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Carl Zeiss Meditec AG (AFX.F)34201.89
MERCK Kommanditgesellschaft auf Aktien (MRK.F)0000N/A

Carl Zeiss Meditec AG (AFX.F) currently has a consensus target price of €102.25, indicating a potential downside of 13.86%. Given Carl Zeiss Meditec AG (AFX.F)'s higher possible upside, research analysts plainly believe Carl Zeiss Meditec AG (AFX.F) is more favorable than MERCK Kommanditgesellschaft auf Aktien (MRK.F).

Dividends

Carl Zeiss Meditec AG (AFX.F) pays an annual dividend of €0.65 per share and has a dividend yield of 0.5%. MERCK Kommanditgesellschaft auf Aktien (MRK.F) pays an annual dividend of €2.60 per share and has a dividend yield of 2.0%. Carl Zeiss Meditec AG (AFX.F) pays out 48.7% of its earnings in the form of a dividend. MERCK Kommanditgesellschaft auf Aktien (MRK.F) pays out 80.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Summary

Carl Zeiss Meditec AG (AFX.F) beats MERCK Kommanditgesellschaft auf Aktien (MRK.F) on 5 of the 9 factors compared between the two stocks.

Carl Zeiss Meditec AG (AFX.F) (ETR:AFX) and Sartorius (ETR:SRT) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Valuation and Earnings

This table compares Carl Zeiss Meditec AG (AFX.F) and Sartorius' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Carl Zeiss Meditec AG (AFX.F)$1.40 billion7.59$119.40 million€1.3488.91
Sartorius$1.99 billion5.62$78.41 million€2.29142.67

Carl Zeiss Meditec AG (AFX.F) has higher earnings, but lower revenue than Sartorius. Carl Zeiss Meditec AG (AFX.F) is trading at a lower price-to-earnings ratio than Sartorius, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Carl Zeiss Meditec AG (AFX.F) and Sartorius' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Carl Zeiss Meditec AG (AFX.F)N/AN/AN/A
SartoriusN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Carl Zeiss Meditec AG (AFX.F) and Sartorius, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Carl Zeiss Meditec AG (AFX.F)34201.89
Sartorius0000N/A

Carl Zeiss Meditec AG (AFX.F) currently has a consensus target price of €102.25, indicating a potential downside of 13.86%. Given Carl Zeiss Meditec AG (AFX.F)'s higher possible upside, research analysts plainly believe Carl Zeiss Meditec AG (AFX.F) is more favorable than Sartorius.

Dividends

Carl Zeiss Meditec AG (AFX.F) pays an annual dividend of €0.65 per share and has a dividend yield of 0.5%. Sartorius pays an annual dividend of €0.35 per share and has a dividend yield of 0.1%. Carl Zeiss Meditec AG (AFX.F) pays out 48.7% of its earnings in the form of a dividend. Sartorius pays out 15.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Carl Zeiss Meditec AG (AFX.F) beats Sartorius on 5 of the 9 factors compared between the two stocks.

Carl Zeiss Meditec AG (AFX.F) (ETR:AFX) and Evotec (ETR:EVT) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

Earnings and Valuation

This table compares Carl Zeiss Meditec AG (AFX.F) and Evotec's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Carl Zeiss Meditec AG (AFX.F)$1.40 billion7.59$119.40 million€1.3488.91
Evotec$470.34 million7.41$34.78 million€0.23100.17

Carl Zeiss Meditec AG (AFX.F) has higher revenue and earnings than Evotec. Carl Zeiss Meditec AG (AFX.F) is trading at a lower price-to-earnings ratio than Evotec, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Carl Zeiss Meditec AG (AFX.F) and Evotec's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Carl Zeiss Meditec AG (AFX.F)N/AN/AN/A
EvotecN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Carl Zeiss Meditec AG (AFX.F) and Evotec, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Carl Zeiss Meditec AG (AFX.F)34201.89
Evotec00403.00

Carl Zeiss Meditec AG (AFX.F) presently has a consensus target price of €102.25, indicating a potential downside of 13.86%. Evotec has a consensus target price of €29.75, indicating a potential upside of 29.12%. Given Evotec's stronger consensus rating and higher possible upside, analysts clearly believe Evotec is more favorable than Carl Zeiss Meditec AG (AFX.F).


Carl Zeiss Meditec AG (AFX.F) Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
BAYN
Bayer
1.0$42.43-0.2%$41.68 billion$43.48 billion-7.42High Trading Volume
Siemens Healthineers logo
SHL
Siemens Healthineers
1.5$38.14-0.4%$38.11 billion$14.73 billion25.80Analyst Report
High Trading Volume
Heavy News Reporting
Fresenius Medical Care AG & Co. KGaA (FME.F) logo
FME
Fresenius Medical Care AG & Co. KGaA (FME.F)
1.8$68.64-2.0%$20.91 billion$18.04 billion15.65Upcoming Earnings
Analyst Report
Heavy News Reporting
MRK
MERCK Kommanditgesellschaft auf Aktien (MRK.F)
0.7$131.85-3.0%$17.04 billion$16.92 billion40.80High Trading Volume
Sartorius logo
SRT
Sartorius
0.6$327.00-1.2%$11.19 billion$1.99 billion142.67High Trading Volume
Heavy News Reporting
Evotec logo
EVT
Evotec
1.3$23.04-0.6%$3.48 billion$470.34 million100.17Analyst Report
MorphoSys AG (MOR.F) logo
MOR
MorphoSys AG (MOR.F)
1.5$88.08-1.2%$2.88 billion$293.21 million26.83
Gerresheimer AG (GXI.F) logo
GXI
Gerresheimer AG (GXI.F)
0.9$87.20-1.3%$2.74 billion$1.38 billion-111.08
Stratec logo
SBS
Stratec
1.0$122.60-7.3%$1.48 billion$232.40 million77.50High Trading Volume
RHÖN-KLINIKUM Aktiengesellschaft (RHK.F) logo
RHK
RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)
0.8$16.46-0.0%$1.10 billion$1.52 billion57.35
Drägerwerk AG & Co. KGaA (DRW3.F) logo
DRW3
Drägerwerk AG & Co. KGaA (DRW3.F)
1.5$70.30-0.6%$604.58 million$2.97 billion14.10
Biotest Aktiengesellschaft (BIO.F) logo
BIO
Biotest Aktiengesellschaft (BIO.F)
0.5$26.40-0.8%$522.34 million$458.80 million-38.37
Medigene AG (MDG1.F) logo
MDG1
Medigene AG (MDG1.F)
1.1$3.51-0.0%$86.22 million$8.57 million-3.77
AEGON logo
AGN
AEGON
0.5N/AN/A$0.00N/A0.00
AMS
Amadeus It Group
0.5N/AN/A$0.00N/A0.00
Bayer logo
BAYN
Bayer
1.5$42.43-0.2%$0.00N/A0.00Analyst Report
High Trading Volume
DIA
DiaSorin
0.6N/AN/A$0.00N/A0.00
Essilor International Société Anonyme (EI.PA) logo
EI
Essilor International Société Anonyme (EI.PA)
0.5$126.85-0.0%$0.00N/A0.00
Fresenius SE & Co. KGaA (FRE.F) logo
FRE
Fresenius SE & Co. KGaA (FRE.F)
1.5$34.37-1.5%$0.00N/A0.00Analyst Report
High Trading Volume
Heavy News Reporting
GNFT
Genfit SA (GNFT.PA)
0.5$3.51-1.1%$0.00N/A0.00High Trading Volume
Heavy News Reporting
Merck KGaA logo
MRK
Merck KGaA
0.9$131.85-3.0%$0.00N/A0.00Analyst Report
High Trading Volume
Novartis logo
NOVN
Novartis
1.3N/AN/A$0.00N/A0.00Analyst Report
Sanofi (SAN.PA) logo
SAN
Sanofi (SAN.PA)
1.2$82.94-0.2%$0.00N/A0.00
Sartorius logo
SRT3
Sartorius
0.8$383.40-2.8%$0.00N/A0.00Analyst Report
High Trading Volume
Sartorius Stedim Biotech S.A. (DIM.PA) logo
DIM
Sartorius Stedim Biotech S.A. (DIM.PA)
0.5$328.00-0.5%$0.00N/A0.00High Trading Volume
STADA Arzneimittel Aktiengesellschaft (SAZ.F) logo
SAZ
STADA Arzneimittel Aktiengesellschaft (SAZ.F)
0.4$80.40-0.0%$0.00N/A0.00Heavy News Reporting
TEV
Teva Pharmaceutical Industries Limited (TEV.F)
0.5N/AN/A$0.00N/A0.00High Trading Volume
This page was last updated on 10/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.